We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Ingenza Embarks on GSK Collaboration
News

Ingenza Embarks on GSK Collaboration

Ingenza Embarks on GSK Collaboration
News

Ingenza Embarks on GSK Collaboration

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Ingenza Embarks on GSK Collaboration "

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

A vital part of any collaboration is the selection of a trusted partner. Andrew Collis, Synthetic Biochemistry Lead in GSK Global Manufacturing and Supply, explained why the company chose to work with Ingenza: “In any external collaboration, it is essential to partner with a company that can quickly and efficiently deliver GSK’s proof of concept. It is important to choose a partner that will interact well with our own scientists, with an established track record in the field. We look for a company with the right technical capabilities, that can understand our objectives and the science involved, and is able to engage in productive dialogue with our scientific staff to drive the project forward in a focused manner. Ingenza is a well-established company, which we believe to have the right skill set, attitude and facilities to progress our project and meet our targets and deadlines.” 

Ian Fotheringham, Managing Director of Ingenza, commented: “Ingenza is delighted to be collaborating with GSK, using its extensive experience in the field to help deliver the project quickly and efficiently. We look forward to establishing an excellent relationship with GSK as the project progresses, working together to advance healthcare developments.”

Advertisement